Inflammation Eye

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

O
OculisZUG, Switzerland
1 program
1
Dexamethasone Ophthalmic SuspensionPhase 31 trial
Active Trials
NCT06128369TerminatedEst. May 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
OculisDexamethasone Ophthalmic Suspension

Clinical Trials (1)

NCT06128369OculisDexamethasone Ophthalmic Suspension

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Start: Dec 2023Est. completion: May 2024
Phase 3Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space